MarketPeel
Insider Trading Intelligence
GT

Glen A. Taylor

COCH
DIRECTOR · ENVOY MEDICAL, INC. · CIK 0001213971
FILING MIX · LIFETIME75%/25%
BUYS
15
SELLS
5
TOTAL VALUE
$28.20M
COMPANIES
1
ACTIVE SINCE
Sep 2023
HOLDINGS NOW
11,250,000
AVG SELL PX
$10.00
TRADE KIND
SHOWING 20 / 20
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
5 backtested trades · 8 horizons · 9 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Glen A. Taylor, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d5+100.00%+160.99%+0.30%+160.69%+39.80%
14d5+100.00%+139.85%+1.20%+138.65%+32.60%
30d5+100.00%+98.80%-0.27%+99.07%+53.74%
60d5+100.00%+83.31%+1.87%+81.44%+20.66%
90d5+100.00%+44.98%+8.43%+36.55%+16.57%
180d5(3 pending)+100.00%+175.26%+14.36%+160.90%+160.90%
1y5(3 pending)+100.00%+57.24%+25.25%+32.00%+32.00%
2y5(3 pending)+0.00%-36.23%+43.46%-79.69%-79.69%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
COCH · 11,250,000 shares · as of Feb 12, 2026
05,425,90210,851,80416,277,70521,703,607202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
FLOW · 15 buys / 5 sellsCOVERAGE · 11 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
COCH
ENVOY MEDICAL, INC.
PURCHASE
18,750,00018,750,000Feb 12, 2026Feb 16, 2026View →
COCH
ENVOY MEDICAL, INC.
PURCHASE
18,750,000$0.40$7.50M21,703,607Feb 12, 2026Feb 16, 2026View →
COCH
ENVOY MEDICAL, INC.
PURCHASE
11,250,00011,250,000Feb 12, 2026Feb 16, 2026View →
COCH
ENVOY MEDICAL, INC.
PURCHASEGRANT
Stock grant
250,000250,000Sep 4, 2025Sep 8, 2025View →
COCH
ENVOY MEDICAL, INC.
SALE
500,0000Sep 4, 2025Sep 8, 2025View →
COCH
ENVOY MEDICAL, INC.
PURCHASEGRANT
Stock grant
750,000750,000Sep 4, 2025Sep 8, 2025View →
COCH
ENVOY MEDICAL, INC.
SALE
250,0000Sep 4, 2025Sep 8, 2025View →
COCH
ENVOY MEDICAL, INC.
SALE
750,0000Sep 4, 2025Sep 8, 2025View →
COCH
ENVOY MEDICAL, INC.
PURCHASEGRANT
Stock grant
500,000500,000Sep 4, 2025Sep 8, 2025View →
COCH
ENVOY MEDICAL, INC.
PURCHASEGRANT
Stock grant
750,000750,000Jun 26, 2025Jul 8, 2025View →
COCH
ENVOY MEDICAL, INC.
PURCHASEGRANT
Stock grant
750,000750,000Mar 11, 2025Mar 13, 2025View →
COCH
ENVOY MEDICAL, INC.
PURCHASEGRANT
Stock grant
500,000500,000Dec 11, 2024Dec 17, 2024View →
COCH
ENVOY MEDICAL, INC.
PURCHASEGRANT
Stock grant
500,000500,000Aug 27, 2024Aug 29, 2024View →
COCH
ENVOY MEDICAL, INC.
PURCHASEGRANT
Stock grant
250,000250,000Jul 22, 2024Jul 24, 2024View →
COCH
ENVOY MEDICAL, INC.
PURCHASEGRANT
Stock grant
250,000250,000May 23, 2024May 28, 2024View →
COCH
ENVOY MEDICAL, INC.
PURCHASE
500,000500,000Feb 27, 2024Mar 4, 2024View →
COCH
ENVOY MEDICAL, INC.
PURCHASE
100,000$10.00$1.00M1,100,000Nov 20, 2023Nov 22, 2023View →
COCH
ENVOY MEDICAL, INC.
SALE
100,000$10.00$1.00M1,000,000Nov 20, 2023Dec 4, 2023View →
COCH
ENVOY MEDICAL, INC.
SALE
1,000,000$10.00$10.00M0Sep 29, 2023Oct 3, 2023View →
COCH
ENVOY MEDICAL, INC.
PURCHASE
869,565$10.00$8.70M869,565Sep 29, 2023Oct 3, 2023View →
Other insiders · COCH
Loading peer insiders…
About this filer
CIK 0001213971
ROLE
Director
PRIMARY
COCH
COMPANIES
1
ACTIVE SINCE
Sep 2023
MARKETPEEL · /INSIDER/0001213971DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback